PEGFILGRASTIM-BMEZ

PEGFILGRASTIM-BMEZ was reported 607 times

PEGFILGRASTIM-BMEZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NAIL BED INFLAMMATION 25 0.0784
1 TARGET SKIN LESION 5 0.0439
2 NASAL MUCOSAL DISORDER 24 0.0412
3 STREPTOCOCCAL SEPSIS 26 0.0219
4 AUTOIMMUNE ANAEMIA 1 0.0182
5 COMPUTERISED TOMOGRAM THORAX 1 0.0167
6 PSEUDOMONAL SEPSIS 26 0.0148
7 CONGENITAL APLASIA 4 0.0129
8 STENOTROPHOMONAS INFECTION 17 0.0125
9 SPINAL CORD PARALYSIS 1 0.0116
10 MEDICAL DEVICE SITE IRRITATION 1 0.0098
11 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
12 PNEUMONIA HERPES VIRAL 1 0.0079
13 CERVICOGENIC HEADACHE 1 0.0074
14 OSTEOCHONDROSIS 8 0.0069
15 VASCULAR DEVICE INFECTION 25 0.0055
16 PARONYCHIA 24 0.0055
17 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
18 REPRODUCTIVE TRACT DISORDER 2 0.0050
19 VARICOSE VEIN 24 0.0046
20 PERIORBITAL INFLAMMATION 1 0.0043
21 ANTIBIOTIC THERAPY 4 0.0041
22 METASTASES TO LYMPH NODES 25 0.0037
23 SPLENIC RUPTURE 5 0.0030
24 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
25 NORMOCYTIC ANAEMIA 4 0.0027
26 NEUROBLASTOMA 1 0.0026
27 VULVOVAGINAL DRYNESS 8 0.0025
28 LYMPHOCYTIC LEUKAEMIA 1 0.0025
29 SPHINCTER OF ODDI DYSFUNCTION 1 0.0024
30 NEUTROPENIC INFECTION 2 0.0021
31 BRAIN OEDEMA 26 0.0021
32 HEPATITIS TOXIC 5 0.0019
33 FEBRILE BONE MARROW APLASIA 8 0.0019
34 OCCIPITAL NEURALGIA 1 0.0018
35 METASTASES TO CENTRAL NERVOUS SYSTEM 22 0.0017
36 ENGRAFTMENT SYNDROME 1 0.0017
37 CANDIDA INFECTION 28 0.0017
38 MEDICAL DEVICE SITE INFECTION 1 0.0016
39 ARTERITIS 1 0.0016
40 FASCIITIS 1 0.0015
41 HEAD AND NECK CANCER 1 0.0015
42 AORTITIS 1 0.0015
43 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
44 DUODENAL ULCER HAEMORRHAGE 4 0.0014
45 SENSITISATION 1 0.0013
46 STOMA SITE HAEMORRHAGE 2 0.0013
47 SKIN FISSURES 24 0.0012
48 FEAR OF FALLING 1 0.0012
49 HYDRONEPHROSIS 9 0.0012
50 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
51 WRONG SCHEDULE 1 0.0010
52 PORTAL HYPERTENSION 3 0.0010
53 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
54 KLEBSIELLA SEPSIS 1 0.0009
55 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
56 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
57 C-REACTIVE PROTEIN INCREASED 29 0.0008
58 CHEMOTHERAPY 3 0.0008
59 SEROMA 1 0.0008
60 RESTLESSNESS 28 0.0008
61 EFFUSION 1 0.0007
62 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
63 BRONCHIAL OBSTRUCTION 1 0.0007
64 PRERENAL FAILURE 1 0.0007
65 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
66 ODYNOPHAGIA 4 0.0007
67 BREAST CANCER METASTATIC 7 0.0007
68 LEUKAEMIA RECURRENT 1 0.0006
69 FIXED ERUPTION 1 0.0006
70 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
71 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
72 BONE MARROW TRANSPLANT 1 0.0005
73 MYELOPATHY 1 0.0005
74 CYSTITIS HAEMORRHAGIC 2 0.0005
75 ECZEMA 24 0.0005
76 PLEURAL EFFUSION 27 0.0004
77 BLOOD LOSS ANAEMIA 1 0.0004
78 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
79 URINARY HESITATION 1 0.0004
80 GASTROINTESTINAL TOXICITY 2 0.0004
81 HYPERTHYROIDISM 6 0.0004
82 PRODUCT PACKAGING CONFUSION 1 0.0004
83 HAEMATOLOGICAL INFECTION 1 0.0004
84 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
85 WHITE BLOOD CELL DISORDER 1 0.0004
86 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
87 SUBDURAL HAEMORRHAGE 1 0.0004
88 NEUTROPENIA 49 0.0004
89 SKIN REACTION 5 0.0004
90 NEUTROPHIL COUNT ABNORMAL 1 0.0004
91 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
92 CYTOKINE RELEASE SYNDROME 7 0.0003
93 FEBRILE NEUTROPENIA 23 0.0003
94 SKIN HAEMORRHAGE 5 0.0003
95 SYMPTOM RECURRENCE 2 0.0003
96 HEPATITIS CHOLESTATIC 2 0.0003
97 INTRACARDIAC THROMBUS 1 0.0003
98 SEPSIS 34 0.0003
99 LYME DISEASE 1 0.0003
100 PLANTAR FASCIITIS 1 0.0003
101 TOXIC SKIN ERUPTION 3 0.0003
102 B-CELL LYMPHOMA 1 0.0003
103 EOSINOPHILIA 5 0.0003
104 NEUTROPENIC SEPSIS 2 0.0003
105 LEUKOPENIA 14 0.0003
106 RASH MACULO-PAPULAR 6 0.0003
107 NEOPLASM MALIGNANT 18 0.0003
108 HYPERTHERMIA 2 0.0003
109 REHABILITATION THERAPY 1 0.0003
110 BLEPHARITIS 1 0.0002
111 NEEDLE ISSUE 7 0.0002
112 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
113 PANCYTOPENIA 13 0.0002
114 HAEMOGLOBIN INCREASED 1 0.0002
115 SKIN TIGHTNESS 1 0.0002
116 LEUKAEMIA 2 0.0002
117 NON-SMALL CELL LUNG CANCER 1 0.0002
118 LIMB OPERATION 1 0.0002
119 ATELECTASIS 2 0.0002
120 PHARYNGEAL SWELLING 2 0.0002
121 ERYSIPELAS 1 0.0002
122 FEEDING DISORDER 4 0.0002
123 HEPATITIS 5 0.0002
124 APLASTIC ANAEMIA 1 0.0002
125 BLOOD LACTIC ACID INCREASED 1 0.0002
126 CYSTIC FIBROSIS 1 0.0002
127 NECROSIS 1 0.0002
128 PRODUCT AVAILABILITY ISSUE 4 0.0002
129 ENTEROCOLITIS 1 0.0002
130 RALES 1 0.0002
131 VASCULITIS 2 0.0002
132 PRODUCT LABEL CONFUSION 1 0.0002
133 BRADYKINESIA 1 0.0002
134 COVID-19 PNEUMONIA 2 0.0002
135 RENAL INJURY 5 0.0002
136 OLIGURIA 1 0.0002
137 CELLULITIS 8 0.0002
138 DEATH 133 0.0002
139 HAEMORRHOIDS 3 0.0002
140 POST-TRAUMATIC STRESS DISORDER 1 0.0001
141 HYPOMAGNESAEMIA 2 0.0001
142 THERMAL BURN 1 0.0001
143 BACK PAIN 32 0.0001
144 BONE PAIN 8 0.0001
145 PSYCHIATRIC SYMPTOM 1 0.0001
146 ARTHROPOD BITE 1 0.0001
147 THROMBOCYTOPENIA 15 0.0001
148 COLITIS 5 0.0001
149 HYPOKALAEMIA 6 0.0001
150 RENAL CYST 1 0.0001
151 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
152 SENSORY LOSS 1 0.0001
153 DECUBITUS ULCER 1 0.0001
154 NEUTROPHIL COUNT DECREASED 5 0.0001
155 BLOOD CREATININE INCREASED 8 0.0001
156 DYSGEUSIA 9 0.0001
157 SKIN PLAQUE 1 0.0001
158 VITAMIN D DECREASED 1 0.0001
159 SKIN SWELLING 1 0.0001
160 RESPIRATORY TRACT INFECTION 3 0.0001
161 SEPTIC SHOCK 5 0.0001
162 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
163 MUCOSAL INFLAMMATION 3 0.0001
164 HYPERKALAEMIA 4 0.0001
165 CARDIOTOXICITY 1 0.0001
166 MYOSITIS 1 0.0001
167 ANAL INCONTINENCE 1 0.0001
168 PNEUMONITIS 3 0.0001
169 ILLNESS 11 0.0001
170 FLANK PAIN 1 0.0001
171 HYPOCALCAEMIA 2 0.0001
172 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
173 THROMBOTIC MICROANGIOPATHY 1 0.0001
174 FULL BLOOD COUNT DECREASED 2 0.0001
175 DRY THROAT 1 0.0001
176 HOSPITALISATION 15 0.0001
177 INFLAMMATION 5 0.0001
178 HYPERBILIRUBINAEMIA 1 0.0001
179 FULL BLOOD COUNT ABNORMAL 1 0.0001
180 RENAL PAIN 1 0.0001
181 ATRIAL FIBRILLATION 9 0.0001
182 ANAEMIA 17 0.0001
183 CHEST DISCOMFORT 9 0.0001
184 INTERNAL HAEMORRHAGE 1 0.0001
185 ELECTROLYTE IMBALANCE 1 0.0001
186 BACTERAEMIA 1 0.0001
187 PYREXIA 29 0.0001
188 PRESYNCOPE 2 0.0001
189 NEURALGIA 2 0.0001
190 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
191 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
192 GENERALISED OEDEMA 1 0.0001
193 VOMITING 37 0.0001
194 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
195 THERAPY CESSATION 4 0.0001
196 ERECTILE DYSFUNCTION 2 0.0001
197 IMMUNE SYSTEM DISORDER 1 0.0001
198 EAR INFECTION 2 0.0001
199 PULMONARY EMBOLISM 7 0.0001
200 DIVERTICULITIS 2 0.0001
201 CARPAL TUNNEL SYNDROME 1 0.0001
202 HYPOACUSIS 3 0.0001
203 PARAESTHESIA ORAL 1 0.0001
204 PANCREATIC CARCINOMA 2 0.0001
205 DYSSTASIA 2 0.0001
206 UNDERDOSE 5 0.0001
207 ABDOMINAL PAIN UPPER 14 0.0001
208 DRY SKIN 9 0.0001
209 COLON CANCER 1 0.0001
210 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
211 SENSORY DISTURBANCE 1 0.0001
212 VIRAL INFECTION 2 0.0001
213 CHEST PAIN 11 0.0001
214 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
215 NEOPLASM PROGRESSION 2 0.0001
216 RASH MACULAR 2 0.0001
217 SYRINGE ISSUE 1 0.0001
218 RASH PRURITIC 3 0.0001
219 OFF LABEL USE 48 0.0001
220 FATIGUE 42 0.0001
221 HEPATIC STEATOSIS 1 0.0001
222 BACTERIAL INFECTION 1 0.0001
223 BLOOD SODIUM DECREASED 1 0.0001
224 ACUTE RESPIRATORY FAILURE 1 0.0001
225 HERNIA 1 0.0001
226 EAR PAIN 1 0.0001
227 CHOKING 1 0.0001
228 KIDNEY INFECTION 1 0.0001
229 SYNCOPE 5 0.0000
230 BLINDNESS 2 0.0000
231 BODY TEMPERATURE INCREASED 1 0.0000
232 NAUSEA 38 0.0000
233 RHABDOMYOLYSIS 2 0.0000
234 URINARY TRACT INFECTION 8 0.0000
235 IRRITABLE BOWEL SYNDROME 1 0.0000
236 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
237 MALAISE 20 0.0000
238 RENAL FAILURE 6 0.0000
239 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
240 TRANSAMINASES INCREASED 1 0.0000
241 RASH PAPULAR 1 0.0000
242 SNEEZING 1 0.0000
243 NEPHROLITHIASIS 2 0.0000
244 DISEASE PROGRESSION 5 0.0000
245 LOCALISED INFECTION 1 0.0000
246 CONSTIPATION 9 0.0000
247 ANAPHYLACTIC SHOCK 1 0.0000
248 HAEMORRHAGE 4 0.0000
249 MUSCULOSKELETAL PAIN 2 0.0000
250 SPEECH DISORDER 2 0.0000
251 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
252 PLATELET COUNT DECREASED 4 0.0000
253 DEHYDRATION 5 0.0000
254 THROAT TIGHTNESS 1 0.0000
255 LIMB INJURY 1 0.0000
256 PALLOR 1 0.0000
257 MENTAL STATUS CHANGES 1 0.0000
258 FEELING COLD 1 0.0000
259 DEMENTIA 1 0.0000
260 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
261 INTENTIONAL DOSE OMISSION 1 0.0000
262 RED BLOOD CELL COUNT DECREASED 1 0.0000
263 ANGINA PECTORIS 1 0.0000
264 HYPERSOMNIA 1 0.0000
265 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
266 RASH 15 0.0000
267 ASCITES 1 0.0000
268 LABORATORY TEST ABNORMAL 1 0.0000
269 URINARY INCONTINENCE 1 0.0000
270 OESOPHAGEAL CARCINOMA 1 0.0000
271 RESPIRATORY DISORDER 1 0.0000
272 ADVERSE DRUG REACTION 3 0.0000
273 APHASIA 1 0.0000
274 STOMATITIS 2 0.0000
275 VERTIGO 2 0.0000
276 LIMB DISCOMFORT 1 0.0000
277 DYSPNOEA 18 0.0000
278 HYPOTHYROIDISM 1 0.0000
279 HIP FRACTURE 1 0.0000
280 INFUSION RELATED REACTION 2 0.0000
281 SKIN DISORDER 1 0.0000
282 URINARY RETENTION 1 0.0000
283 GAIT INABILITY 1 0.0000
284 CONDITION AGGRAVATED 9 0.0000
285 HAEMOGLOBIN DECREASED 3 0.0000
286 HAEMATURIA 1 0.0000
287 HYPOXIA 1 0.0000
288 THERAPY INTERRUPTED 2 0.0000
289 INFECTION 4 0.0000
290 HYPERGLYCAEMIA 1 0.0000
291 PANIC ATTACK 1 0.0000
292 DRUG INEFFECTIVE 36 0.0000
293 EPISTAXIS 2 0.0000
294 DYSPNOEA EXERTIONAL 1 0.0000
295 ACNE 2 0.0000
296 ACUTE KIDNEY INJURY 4 0.0000
297 DRUG DOSE OMISSION BY DEVICE 2 0.0000
298 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
299 EXTRA DOSE ADMINISTERED 1 0.0000
300 CARDIO-RESPIRATORY ARREST 1 0.0000
301 ROAD TRAFFIC ACCIDENT 1 0.0000
302 MYALGIA 4 0.0000
303 BALANCE DISORDER 2 0.0000
304 LIVER DISORDER 1 0.0000
305 MEMORY IMPAIRMENT 3 0.0000
306 PNEUMONIA 7 0.0000
307 HYPERSENSITIVITY 4 0.0000
308 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
309 ASTHENIA 8 0.0000
310 DRUG INTOLERANCE 2 0.0000
311 PRODUCT DOSE OMISSION ISSUE 6 0.0000
312 DYSPEPSIA 2 0.0000
313 DIARRHOEA 13 0.0000
314 DIZZINESS 10 0.0000
315 PERIPHERAL SWELLING 3 0.0000
316 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
317 OEDEMA 1 0.0000
318 HAEMATOCHEZIA 1 0.0000
319 MEDICATION ERROR 1 0.0000
320 NECK PAIN 1 0.0000
321 HYPONATRAEMIA 1 0.0000
322 SEIZURE 2 0.0000
323 SURGERY 1 0.0000
324 ILL-DEFINED DISORDER 1 0.0000
325 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
326 GAIT DISTURBANCE 3 0.0000
327 DEEP VEIN THROMBOSIS 1 0.0000
328 ALOPECIA 3 0.0000
329 DEVICE DIFFICULT TO USE 1 0.0000
330 HYPOTENSION 3 0.0000
331 PRODUCT QUALITY ISSUE 2 0.0000
332 BURNING SENSATION 1 0.0000
333 DEVICE MALFUNCTION 1 0.0000
334 MOBILITY DECREASED 1 0.0000
335 RESPIRATORY FAILURE 1 0.0000
336 AGITATION 1 0.0000
337 CHRONIC KIDNEY DISEASE 1 0.0000
338 INJECTION SITE SWELLING 1 0.0000
339 ABDOMINAL PAIN 3 0.0000
340 PARAESTHESIA 2 0.0000
341 INFLUENZA LIKE ILLNESS 1 0.0000
342 INTENTIONAL PRODUCT MISUSE 1 0.0000
343 COVID-19 2 0.0000
344 TACHYCARDIA 1 0.0000
345 GASTROINTESTINAL DISORDER 1 0.0000
346 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
347 MUSCLE SPASMS 2 0.0000
348 ADVERSE EVENT 1 0.0000
349 NASOPHARYNGITIS 2 0.0000
350 OROPHARYNGEAL PAIN 1 0.0000
351 BREAST CANCER 1 0.0000
352 SWELLING 1 0.0000
353 PRODUCT USE ISSUE 2 0.0000
354 DYSPHAGIA 1 0.0000
355 MIGRAINE 1 0.0000
356 PAIN IN EXTREMITY 3 0.0000
357 SOMNOLENCE 2 0.0000
358 INJECTION SITE PAIN 3 0.0000
359 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
360 ERYTHEMA 2 0.0000
361 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
362 PALPITATIONS 1 0.0000
363 CHILLS 1 0.0000
364 FEELING ABNORMAL 2 0.0000
365 HEADACHE 5 0.0000
366 LOSS OF CONSCIOUSNESS 1 0.0000
367 VISION BLURRED 1 0.0000
368 ARTHRALGIA 3 0.0000
369 COUGH 2 0.0000
370 ANXIETY 2 0.0000
371 HYPOAESTHESIA 1 0.0000
372 DRUG INTERACTION 1 0.0000
373 FALL 2 0.0000
374 URTICARIA 1 0.0000
375 ABDOMINAL DISCOMFORT 1 0.0000
376 TOXICITY TO VARIOUS AGENTS 1 0.0000
377 CEREBROVASCULAR ACCIDENT 1 0.0000
378 NO ADVERSE EVENT 1 0.0000
379 PAIN 3 0.0000
380 HYPERTENSION 1 0.0000
381 DEPRESSION 1 0.0000
382 INCORRECT DOSE ADMINISTERED 1 0.0000
383 DECREASED APPETITE 1 0.0000
384 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000